Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Woosley

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
Journal of Women'S Health|March 25, 1998
From bench to bedside: role of gender-based therapeutics in the clinical care of womenR L Woosley
Annals of Internal Medicine|March 1, 1988
Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of dataR L Woosley
The American Journal of Cardiology|October 19, 1988
Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugsR L Woosley
Clinical Pharmacology and Therapeutics|March 1, 1994
Centers for education and research in therapeuticsR L Woosley
Clinical Pharmacology and Therapeutics|May 1, 1990
CAST: implications for drug developmentR L Woosley
Pharmacogenetics|February 1, 1992
Clinical implications of variable antiarrhythmic drug metabolismE Buchert, R L Woosley
Clinical Pharmacology and Therapeutics|December 23, 2006
Drug development and the FDA's Critical Path InitiativeR L Woosley, J Cossman
The American Journal of Cardiology|August 26, 1993
QT interval: a measure of drug actionR L Woosley, M Sale
The New England Journal of Medicine|July 3, 1986
Drug therapy. FlecainideD M Roden, R L Woosley
Clinical Pharmacokinetics|May 1, 1986
Clinical pharmacokinetics of disopyramideL A Siddoway, R L Woosley
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
Journal of Women'S Health|March 25, 1998
From bench to bedside: role of gender-based therapeutics in the clinical care of womenR L Woosley
Annals of Internal Medicine|March 1, 1988
Indications for antiarrhythmic therapy: a wealth of controversy, a dearth of dataR L Woosley
The American Journal of Cardiology|October 19, 1988
Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugsR L Woosley
Clinical Pharmacology and Therapeutics|March 1, 1994
Centers for education and research in therapeuticsR L Woosley
Clinical Pharmacology and Therapeutics|May 1, 1990
CAST: implications for drug developmentR L Woosley
Pharmacogenetics|February 1, 1992
Clinical implications of variable antiarrhythmic drug metabolismE Buchert, R L Woosley
Clinical Pharmacology and Therapeutics|December 23, 2006
Drug development and the FDA's Critical Path InitiativeR L Woosley, J Cossman
The American Journal of Cardiology|August 26, 1993
QT interval: a measure of drug actionR L Woosley, M Sale
The New England Journal of Medicine|July 3, 1986
Drug therapy. FlecainideD M Roden, R L Woosley
Clinical Pharmacokinetics|May 1, 1986
Clinical pharmacokinetics of disopyramideL A Siddoway, R L Woosley
Pageof 21